Insight

Pratiti Bandopadhayay: The Clinical Significance of FGFR-Alterations Across Pediatric Gliomas

Pratiti Bandopadhayay/dana-farber.org

Aug 1, 2025, 14:57

Pratiti Bandopadhayay: The Clinical Significance of FGFR-Alterations Across Pediatric Gliomas

Pratiti Bandopadhayay, Associate Professor of Pediatrics at Harvard Medical School, shared a post on LinkedIn about a recent article by April A. Apfelbaum et al. published in Nature Communications:

“Very excited to share our paper reporting the clinical significance of FGFR-alterations across pediatric gliomas.

We still have a lot of work to do until we get to our goal of having targeted inhibitors for children diagnosed with these gliomas, but are hoping that this work increases awareness around the need for drug development and access to drugs for children.

Congratulations to first authors April Apfelbaum and Eric Morin and to everyone across BandoLab and Ligon Lab and our collaborators who spearheaded this project and contributed. And a massive thank you to all of the foundations and patients and their families without whom this would have been impossible.”

Title: A diverse landscape of FGFR alterations andco-mutations suggests potential therapeuticstrategies in pediatric low-grade gliomas

Authors: April A. Apfelbaum, Eric Morin, Dominik Sturm, Georges Ayoub, Jeromy DiGiacomo, Sher Bahadur, Bhavyaa Chandarana, Phoebe C. Power, Margaret M. Cusick, Dana Novikov, Prem Prabhakar, Robert E. Jones, Jayne Vogelzang, Connor C. Bossi, Seth Malinowski, Lewis M. Woodward, Tania A. Jones, John Jeang, Sarah W. Lamson, Jared Collins, Kelly Y. Cai, Jacquelyn S. Jones, Sehee Oh, Hyesung Jeon, Jinhua Wang, Amy Cameron, Patrick Rechter, Angela De Leon, Karthikeyan Murugesan, Meagan Montesion, Lee A. Albacker, Shakti H. Ramkissoon, Cornelis M. van Tilburg, Emily C. Hardin, Philipp Sievers, Felix Sahm, Kee Kiat Yeo, Tom Rosenberg, Susan N. Chi, Karen D. Wright, Steven Hébert, Sydney Peck, Alberto Picca, Valérie Larouche, Samuele Renzi, Sara J. Buhrlage, Tejus A. Bale, Amy A. Smith, Mehdi Touat, Nada Jabado, Eric S. Fischer, Michael J. Eck, Lissa Baird, Olaf Witt, Claudia L. Kleinman, Quang-De Nguyen, Denise Sheer, Sanda Alexandrescu, David T. W. Jones, Keith L. Ligon, Pratiti Bandopadhayay

Read the Full Article on Nature Communications

Pratiti Bandopadhayay: The Clinical Significance of FGFR-Alterations Across Pediatric Gliomas

More posts featuring Pratiti Bandopadhayay.

Alberto Picca Amy A. Smith Amy Cameron Angela De Leon April A. Apfelbaum BandoLab Bhavyaa Chandarana cancer Claudia L. Kleinman Connor C. Bossi Cornelis M. van Tilburg Dana Novikov David T. W. Jones Denise Sheer Dominik Sturm Emily C. Hardin Eric Morin Eric S. Fischer Felix Sahm Georges Ayoub gliomas Hyesung Jeon Jacquelyn S. Jones Jared Collins Jayne Vogelzang Jeromy DiGiacomo Jinhua Wang John Jeang Karen D. Wright Karthikeyan Murugesan Kee Kiat Yeo Keith L. Ligon Kelly Y. Cai Lee A. Albacker Lewis M. Woodward Ligon Lab Lissa Baird Margaret M. Cusick Meagan Montesion Mehdi Touat Michael J. Eck Nada Jabado Olaf Witt OncoDaily Oncology Patrick Rechter Philipp Sievers Phoebe C. Power Pratiti Bandopadhayay Prem Prabhakar Quang-De Nguyen Robert E. Jones Samuele Renzi Sanda Alexandrescu Sara J. Buhrlage Sarah W. Lamson Sehee Oh Seth Malinowski Shakti H. Ramkissoon Sher Bahadur Steven Hébert Susan N. Chi Sydney Peck Tania A. Jones Tejus A. Bale Tom Rosenberg Valérie Larouche

Kirsty Duncan։ Thirty-two Months Into Fighting Cancer...

World’s Nicest Judge Frank Caprio Dies at 88 After Brave Battle with Pancreatic Cancer

IMvigor011 Trial Reports ctDNA as Predictor of Response to Adjuvant Atezolizumab in Bladder Cancer

Ruben Mesa is Starting a New Position as President of Cancer National Service Line at Advocate Health

Patrick Soon-Shiong: 30 Years and $3B Toward a Universal Cancer Fighter